We Give Shareholders a Voice

Acceleron Pharma Inc. Information Request Form

Levi & Korsinsky announces it has commenced an investigation of Acceleron Pharma Inc. (NASDAQ: XLRN) concerning possible breaches of fiduciary duty.

To receive more information, please fill out the form.

Enter Your Detail Below

This submission does not create an attorney-client relationship. We will keep you up to date with this investigation, and should this investigation evolve, we will contact you to discuss whether to establish an attorney client relationship at no cost to you.

Review our Privacy Policy

All Rights Reserved. © 2023 Levi & Korsinsky, LLP

Attorney Advertising. No part of this website or any of its content or images may be reproduced, copied, modified or adapted,

without the prior express written consent of Levi & Korsinsky, LLP. Prior results do not guarantee a similar outcome.